After PPARγ was identified as a mature positive regulator of adipogenesis and lipid storage in 2013, inhibition of PPARγ was reported to reduce aldehyde dehydrogenase (ALDH) activity in ERBB2-positive breast cancer cells. The gene discussed is PPARG; the disease is breast carcinoma.